Log In
Print
BCIQ
Print
Print this Print this
 

Fumaderm

  Manage Alerts
Collapse Summary General Information
Company Biogen Inc.
DescriptionOral oral combination of dimethyl fumarate and monoethyl fumarate salts
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$761.0M

$220.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today